Target discovery and validation in tuberculosis

被引：0
|
作者：
Dick, Thomas [1 ]
机构：
[1] Novartis Inst Trop, Dis Pte, Singapore, Singapore
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Monobodies as tool biologics for accelerating target validation and druggable site discovery
    Akkapeddi, Padma
    Teng, Kai Wen
    Koide, Shohei
    RSC MEDICINAL CHEMISTRY, 2021, 12 (11): : 1839 - 1853
  • [42] Molecular target validation and discovery in transgenic mouse models of cancer prevention
    Colburn, N
    Young, MR
    Matthews, C
    Bowden, T
    Jansen, AP
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1368S - 1369S
  • [43] New collaboration aims to aid target validation and drive drug discovery
    Wilson, Hannah
    PHARMACOGENOMICS, 2014, 15 (06) : 732 - 732
  • [44] Bioinformatic application in proteomic research on biomarker discovery and drug target validation
    Wang, Ying
    Chiu, Jen-Fu
    He, Qing-Yu
    CURRENT BIOINFORMATICS, 2007, 2 (01) : 11 - 20
  • [45] CRISPR-Cas9: A tool for rapid target discovery and validation
    Wiggins, Ceri M.
    Walter, David
    Russell, Paul
    Sheridan, Clare
    Hudson, Chantelle
    Yarker, Joanne
    le Sage, Carlos
    McCarthy, Nicola
    Moore, Jonathan D.
    CANCER RESEARCH, 2018, 78 (13)
  • [46] In vitro platforms representing tumor complexity for target validation and drug discovery
    Hickman, John A.
    CANCER RESEARCH, 2013, 73 (08)
  • [47] The role of murine models of prostate cancer in drug target discovery and validation
    Ahmad, Imran
    Sansom, Owen J.
    Leung, Hing Y.
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (08) : 879 - 888
  • [48] Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target
    Ollinger, Juliane
    O'Malley, Theresa
    Kesicki, Edward A.
    Odingo, Joshua
    Parish, Tanya
    JOURNAL OF BACTERIOLOGY, 2012, 194 (03) : 663 - 668
  • [49] Current possibilities and unresolved issues of drug target validation in Mycobacterium tuberculosis
    Sharma, Umender
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (11) : 1171 - 1186
  • [50] Discovery of novel lysine ε-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis
    Devi, Parthiban Brindha
    Sridevi, Jonnalagadda Padma
    Kakan, Shruti Singh
    Saxena, Shalini
    Jeankumar, Variam Ullas
    Soni, Vijay
    Anantaraju, Hasitha Shilpa
    Yogeeswari, Perumal
    Sriram, Dharmarajan
    TUBERCULOSIS, 2015, 95 (06) : 786 - 794
12345